Landscapes / Companies
Spinogenix not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
Drugs
2
in active trials
Trials
4 active
8 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | 31 Dec 2027Phase 2/3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Alzheimer Disease, Schizophrenia and 1 more | ||||
| Open drug page | |||||
— |
Phase 2/3 | 1 Feb 2030Phase 2/3 trial completes | |||
| Next date | 1 Feb 2030 · Phase 2/3 trial completes | ||||
| Also tested for | Fragile X Syndrome (FXS), Autism Spectrum Disorder (ASD) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021